Menu
ÚHKT

Impaktované publikace

[1]

Holoubek, A.; Strachotová, D.; Otevřelová, P.; Röselová, P.; Heřman, P.; Brodská, B.

AML-related NPM mutations drive p53 delocalization into the cytoplasm with possible impact on p53-dependent stress response

[rok vydání 2021, impact factor 6.639 ]

[2]

Antonarakis, S.E.; Holoubek, A.; Rapti, M.; Rademaker, J.; Meylan, J.; Iwaszkiewicz, J.; Zoete, V.; Ansar, M.; Borel, CH.; Menzel, O.; Kuzelova, K.; Santoni, F.A.

Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2

[rok vydání 2020, impact factor 6.150 ]

[3]

Šašinková, M.; Heřman, P.; Holoubek, A.; Strachotová, D.; Otevřelová, P.; Grebeňová, D.; Kuželová, K.; Brodská, B.

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization

[rok vydání 2020, impact factor 4.379 ]

[4]

Grebeňová, D.; Holoubek, A.; Röselová, P.; Obr, A.; Brodská, B.; Kuželová, K.

PAK1, PAK1delta15, and PAK2: similarities, differences and mutual interactions

[rok vydání 2019, impact factor 3.998 ]

[5]

Kasim, N.R.; Kuželová, K.; Holoubek, A.; Model, M.A.

Live fluorescence and transmission-through-dye microscopic study of actinomycin D-induced apoptosis and apoptotic volume decrease

[rok vydání 2013, impact factor 3.614 ]

[6]

Brodská, B.; Otevřelová, P.; Holoubek, A.

Decitabine and SAHA-induced apoptosis is accompanied by survivin downregulation and potentiated by ATRA in p53-deficient cells

[rok vydání 2014, impact factor 3.516 ]

[7]

Kuželová, K.; Obr, A.; Röselová, P.; Grebeňová, D.; Otevřelová, P.; Brodská, B.; Holoubek, A.

Group I p21-activated kinases in leukemia cell adhesion to fibronectin

[rok vydání 2020, impact factor 3.405 ]

[8]

Röselová, P.; Obr, A.; Holoubek, A.; Grebeňová, D.; Kuželová, K.

Adhesion structures in leukemia cells and their regulation by Src family kinases

[rok vydání 2017, impact factor 3.296 ]

[9]

Kuželová, K.; Grebeňová, D.; Holoubek, A.; Röselová, P.; Obr, A.

Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells

[rok vydání 2014, impact factor 3.234 ]

[10]

Šašinková, M.; Holoubek, A.; Otevřelová, P.; Kuželová, K.; Brodská, B.

AML-associated mutation of nucleophosmin compromises its interaction with nucleolin

[rok vydání 2018, impact factor 3.144 ]

[11]

Brodská, B.; Holoubek, A.; Otevřelová, P.; Kuželová, K.

Low-dose actinomycin-D induces redistribution of wild-type and mutated nucleophosmin followed by cell death in leukemic cells

[rok vydání 2015, impact factor 3.085 ]

[12]

Holoubek, A.; Heřman, P.; Sýkora, J.; Brodská, B.; Humpolíčková, J.; Kráčmarová, M.; Gášková, D.; Hof, M.; Kuželová, K.

Monitoring of nucleophosmin oligomerization in live cells

[rok vydání 2018, impact factor 2.940 ]

[13]

Brodská, B.; Holoubek, A.

Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors

[rok vydání 2011, impact factor 2.841 ]

[14]

Brodská, B.; Kráčmarová, M.; Holoubek, A.; Kuželová, K.

Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM

[rok vydání 2017, impact factor 2.766 ]

[15]

Brodská, B.; Otevřelová, P.; Holoubek, A.

Erratum to: Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA

[rok vydání 2012, impact factor 2.329 ]

[16]

Brodská, B.; Otevřelová, P.; Holoubek, A.

Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA

[rok vydání 2010, impact factor 2.057 ]